TARRYTOWN, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (:PBH) today announced that it will participate in the 2023 ICR Conference and is scheduled to host a fireside chat Tuesday, January 10, 2023 at 2:30 p.m. Eastern Time. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investorsā section and the "Events and Presentations" tab, or by using the following link:
https://ir.prestigebrands.com/events-presentations/events
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Companyās diverse portfolio of brands include MonistatĀ® and Summerās EveĀ® women's health products, BCĀ® and Goody'sĀ® pain relievers, Clear EyesĀ® and TheraTearsĀ® eye care products, DenTekĀ® specialty oral care products, DramamineĀ® motion sickness treatments, FleetĀ® enemas and glycerin suppositories, ChlorasepticĀ® and Luden'sĀ® sore throat treatments and drops, Compound WĀ® wart treatments, Little RemediesĀ® pediatric over-the-counter products, Boudreauxās Butt PasteĀ® diaper rash ointments, NixĀ® lice treatment, DebroxĀ® earwax remover, GavisconĀ® antacid in Canada, and HydralyteĀ® rehydration products and the FessĀ® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
[email protected]
